Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
The Comprehensive Sickle Cell and Thalassemia Program is home to over 280 children, adolescents and young adults, with sickle cell anemia and other disorders of hemoglobin including beta thalassemia, emphasizing primary, secondary and tertiary prevention and treatment using a multidisciplinary team approach. Children’s program is recognized as one of six selected clinical centers for the management of children with sickle cell anemia by the Ohio Department of health, and oversees newborn screening, counseling, clinical management of acute complications and long-term follow–up care for the largest region of the state.
Children’s highly specialized services include state-of-the-art screening and management of cerebrovasular, neurologic, cardiac and hepatobiliary complications. Our experts also provide complete transfusion support services, iron overload management, clinical psychological testing and follow-up, diagnostic testing and counseling and bone marrow transplantation. We are a leader in quality of life research in sickle cell anemia and participate in a variety of federally-funded clinical trials in sickle cell and thalassemia. This physician lead team includes a nurse practitioner, social worker, psychologist, nutritionist, nurse clinician, program coordinator, pastoral care and newborn screening coordinator.
+myBinderRelated Content
-
Provider Perspectives of Necessary Factors in Sickle Cell Disease Health Care Transition: Results from an Online Sur...Introduction: Survivorship of children w...
-
Tim Townes, PhDTim M. Townes (b.1951), Professor and Ch...
-
Lamia Barakat, PhDLamia P. Barakat, PhD, is the Director o...
-
A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD)Limited evidence guides opioid dosing st...
-
University of Illinois at Chicago awarded $4.6 million NIH grant for chronic pain researchThe University of Illinois at Chicago ha...
-
Sancilio Pharmaceuticals Company, Inc. Announces Completion of Enrollment in the SCOT Trial in Pediatric Patients Wi...Sancilio Pharmaceuticals Company, Inc. (...
-
SCDAA And MedicAlert Pilot Program ApplicationSCDAA and MedicAlert Pilot Program Impr...
